Cited by 1,033Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceEnterobacteriaceae and Cronobacter Research

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Gupta, N., Limbago, B. M., Patel, J. B., Kallen, A. J.·2011·Clinical Infectious Diseases

Open this paper in CoChat — free account

Abstract

Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes, including New Delhi metallo-β-lactamase, have been identified among Enterobacteriaceae in the United States. Like KPC, these enzymes are frequently found on mobile genetic elements and have the potential to spread widely. As a result, preventing both CRE transmission and CRE infections have become important public health objectives. This review describes the current epidemiology of CRE in the United States and highlights important prevention strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/cid/cir202

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Self-citation
Infectious Diseases Society of America
Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,531
Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009
Gould, C. V., Umscheid, C. A., Agarwal, R. K., Kuntz, G. M., & Pegues, D. A. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651091 · Cited by 1,406
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M. M., & Chiarello, L. A. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,304
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Patel, G., Huprikar, S. S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/592412 · Cited by 837
The New β-Lactamases
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 806

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 1

2009, MMWR. Morbidity and mortality weekly report, 58, 256

Sorted by citations

Items 201–300 of 1,000

Spread of Carbapenem-ResistantEnterobacteriaceaeAmong Illinois Healthcare Facilities: The Role of Patient Sharing
Ray, M. J., Lin, M. Y., Weinstein, R. A., & Trick, W. E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw461 · Cited by 61
From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria
Hammad, A., Abutaleb, N. S., Elsebaei, M. M., Norvil, A. B., Alswah, M., Ali, A. O., Abdel-Aleem, J. A., Alattar, A., Bayoumi, S. A., Gowher, H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00720 · Cited by 61
Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin?
Carlet, J. M., & Mainardi, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03702.x · Cited by 60
Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS)
Koppe, U., von Laer, A., Kroll, L. E., Noll, I., Feig, M., Schneider, M., Claus, H., Eckmanns, T., & Sin, M. A. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0362-9 · Cited by 60
Rapid detection of the Klebsiella pneumoniae carbapenemase (KPC) gene by loop-mediated isothermal amplification (LAMP)
Nakano, R., Nakano, A., Ishii, Y., Ubagai, T., Kikuchi‐Ueda, T., Kikuchi, H., Tansho‐Nagakawa, S., Kamoshida, G., Mu, X., & Ono, Y. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.11.010 · Cited by 60
KPC-4 Is Encoded within a Truncated Tn 4401 in an IncL/M Plasmid, pNE1280, Isolated from Enterobacter cloacae and Serratia marcescens
Bryant, K. A., Schooneveld, T. C. V., Thapa, I., Bastola, D. K., Williams, L. O., Safranek, T. J., Hinrichs, S. H., Rupp, M. E., & Fey, P. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01062-12 · Cited by 60
In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
Hornsey, M., Longshaw, C. M., Phee, L. M., & Wareham, D. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05870-11 · Cited by 60
Development of novel antibacterial drugs to combat multiple resistant organisms
Bassetti, M., & Righi, E. (2015) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-015-1280-4 · Cited by 60
Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India
Mittal, G., Gaind, R., Kumar, D., Kaushik, G., Gupta, K. B., Verma, P. K., & Deb, M. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0763-y · Cited by 60
Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa
Singh-Moodley, A., & Perovic, O. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1858-7 · Cited by 60
VIM ‐1 carbapenemase‐producing Escherichia coli in gulls from southern France
Vittecoq, M., Laurens, C., Brazier, L., Durand, P., Elguero, É., Arnal, A., Frédéric Thomas, A., Aberkane, S., Renaud, N., Prugnolle, F., et al. (2017) · Ecology and Evolution · doi:10.1002/ece3.2707 · Cited by 60
Horizontal transfer of the blaNDM-1 gene to Pseudomonas aeruginosa and Acinetobacter baumannii in biofilms
Tanner, W. D., Atkinson, R. M., Goel, R. K., Toleman, M. A., Benson, L. S., Porucznik, C. A., & VanDerslice, J. A. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx048 · Cited by 60
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants
Rhee, E. G., Rizk, M. L., Calder, N. A., Nefliu, M., Warrington, S., Schwartz, M. S., Mangin, E. C., Boundy, K. E., Bhagunde, P. R., Colón‐González, F., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-18 · Cited by 60
Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae
Hirsch, E. B., Guo, B., Chang, K., Cao, H., Ledesma, K. R., Singh, M., & Tam, V. H. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis766 · Cited by 59
Antibiotic resistance and virulence patterns of pathogenic Escherichia coli strains associated with acute gastroenteritis among children in Qatar
Eltai, N. O., Thani, A. A. A., Al-Hadidi, S. H., Alansari, K., & Yassine, H. M. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01732-8 · Cited by 61
Venturicidin A, A Membrane-active Natural Product Inhibitor of ATP synthase Potentiates Aminoglycoside Antibiotics
Yarlagadda, V., Medina, R., & Wright, G. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-64756-0 · Cited by 59
Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan
Chang, Y.-Y., Chuang, Y.-C., Siu, L.-K. K., Wu, T.-L., Lin, J., Lu, P., Wang, J., Wang, L.-S., Lin, Y.-T., Huang, L., et al. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.05.010 · Cited by 58
Bloodstream infections caused by carbapenemase-producingKlebsiella pneumoniae: a clinical perspective
Daikos, G. L., Markogiannakis, A., Souli, M., & TZOUVELEKIS, L. S. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.138 · Cited by 58
Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates
Tang, H.-J., Hsieh, C., Chang, P., Chen, J.-J., Lin, Y., Lai, C., Chao, C., & Chuang, Y.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151897 · Cited by 58
Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2)
Pemberton, O. A., Zhang, X., & Chen, Y. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00158 · Cited by 58
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007–2009 SENTRY Antimicrobial Surveillance Program
Kaiser, R., Castanheira, M., Jones, R. N., Tenover, F. C., & Lynfield, R. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.032 · Cited by 57
Molecular Epidemiology and Genome Dynamics of New Delhi Metallo-β-Lactamase-Producing Extraintestinal Pathogenic Escherichia coli Strains from India
Ranjan, A. K., Shaik, S., Mondal, A., Nandanwar, N., Hussain, A., Semmler, T., Kumar, N., Tiwari, S. K., Jadhav, S., Wieler, L. H., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01345-16 · Cited by 57
GUT COLONIZATION WITH CARBAPENEM RESISTANT ENTEROBACTERIACEAE ADVERSELY IMPACTS THE OUTCOME IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A PROSPECTIVE SURVEILLANCE STUDY
Chakrabarti, S. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.025 · Cited by 57
Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis
Zhong, H., Zhao, X., Zhang, Z.-L., Gu, Z., Zhang, C., Gao, Y., & Cui, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.07.004 · Cited by 57
The spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and prevention
Brink, A. J., Coetzee, J., Clay, C. G., Corcoran, C., van Greune, J., Deetlefs, J. D., Nutt, L., Feldman, C. H., Richards, G. A., Nordmann, P., et al. (2012) · South African Medical Journal · doi:10.7196/samj.5789 · Cited by 56
Population-Based Incidence of Carbapenem-Resistant Klebsiella pneumoniae along the Continuum of Care, Los Angeles County
Márquez, P., Terashita, D. M., Dassey, D. E., & Mascola, L. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/669087 · Cited by 56
Statewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan
Brennan, B. M., Coyle, J. R., Marchaim, D., Pogue, J. M., Boehme, M. S., Finks, J. L., Malani, A. N., VerLee, K. E., Buckley, B. O., Mollon, N., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675611 · Cited by 56
Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests
Laolerd, W., Akeda, Y., Preeyanon, L., Ratthawongjirakul, P., & Santanirand, P. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0080 · Cited by 56
Prevalence and characterization of carbapenem‐resistant bacteria in water bodies in the Los Angeles–Southern California area
Harmon, D. E., Miranda, O. A., McCarley, A., Eshaghian, M., Carlson, N. M., & Ruiz, C. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.692 · Cited by 56
Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance
Folgori, L., & Bielicki, J. A. (2019) · Journal of Pediatric Intensive Care · doi:10.1055/s-0038-1677535 · Cited by 58
Dissemination of NDM Metallo-β-Lactamase Genes among Clinical Isolates of Enterobacteriaceae Collected during the SMART Global Surveillance Study from 2008 to 2012
Biedenbach, D. J., Bouchillon, S. K., Hackel, M., Hoban, D. J., Kazmierczak, K. M., Hawser, S., & Badal, R. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03938-14 · Cited by 55
Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
Galdadas, I., Lovera, S., Pérez‐Hernández, G., Barnes, M. D., Healy, J., Afsharikho, H., Woodford, N., Bonomo, R. A., Gervasio, F. L., & Haider, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31176-0 · Cited by 57
Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae
Martirosov, D. M., & Lodise, T. P. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.008 · Cited by 55
Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
Hong, J. H., Clancy, C. J., Cheng, S., Shields, R. K., Chen, L., Doi, Y., Zhao, Y., Perlin, D. S., Kreiswirth, B. N., & Nguyen, M. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02411-12 · Cited by 55
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
Bono, V. D., Giacobbe, D. R., Marchese, A. E., Parisini, A., Fucile, C., Coppo, E., Marini, V., Arena, A., Molin, A., Martelli, A., et al. (2016) · Virulence · doi:10.1080/21505594.2016.1213476 · Cited by 55
Outbreaks in Health Care Settings
Sood, G., & Perl, T. M. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.04.003 · Cited by 57
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
Mansour, H., Ouweini, A. E., Chahine, E. B., & Karaoui, L. R. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab012 · Cited by 55
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization
Koh, J.-J., Lin, H., Caroline, V., Chew, Y. S., Pang, L. M., Aung, T. T., Li, J., Lakshminarayanan, R., Tan, D. T. H., Verma, C. S., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00628 · Cited by 54
Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital
Chotiprasitsakul, D., Srichatrapimuk, S., Kirdlarp, S., Pyden, A., & Santanirand, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s192540 · Cited by 54
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections
Alosaimy, S., Jorgensen, S. C. J., Lagnf, A. M., Melvin, S. M., Mynatt, R. P., Carlson, T. J., Garey, K. W., Allen, D., Venugopalan, V., Veve, M. P., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa051 · Cited by 54
Pediatric Multicenter Evaluation of the Verigene Gram-Negative Blood Culture Test for Rapid Detection of Inpatient Bacteremia Involving Gram-Negative Organisms, Extended-Spectrum Beta-Lactamases, and Carbapenemases
Sullivan, K. V., DeBurger, B., Roundtree, S. S., Ventrola, C., Blecker-Shelly, D., & Mortensen, J. E. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00737-14 · Cited by 53
Dissemination of bla OXA-23 in Acinetobacter spp. in China: Main Roles of Conjugative Plasmid pAZJ221 and Transposon Tn 2009
Liu, L.-L., Ji, S., Ruan, Z., Fu, Y., Fu, Y., Wang, Y., & Yu, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04574-14 · Cited by 53
Analysis of Antibiotic Resistance and Virulence Traits (Genetic and Phenotypic) in Klebsiella pneumoniae Clinical Isolates from Pakistan: Identification of Significant Levels of Carbapenem and Colistin Resistance
Imtiaz, W., Syed, Z., Rafaque, Z., Andrews, S. C., & Dasti, J. I. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s293290 · Cited by 53
Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting
Gagliotti, C., Ciccarese, V., Sarti, M., Giordani, S., Barozzi, A., Braglia, C., Gallerani, C., Gargiulo, R., Lenzotti, G., Manzi, O., et al. (2013) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.11.024 · Cited by 52
Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
Denys, G. A., Callister, S. M., & Dowzicky, M. J. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-24 · Cited by 52
Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011)
Flamm, R. K., Sader, H. S., Farrell, D. J., & Jones, R. N. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.005 · Cited by 52
Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice
Yang, C. H., Lou, W., Zhong, G., Lee, A. L. Z., Leong, J., Chin, W., Ding, B., Bao, C., Tan, J. P. K., Pu, Q., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.057 · Cited by 52
Carbapenem‐resistant K lebsiella pneumoniaeinfections in kidney transplant recipients: a case–control study
Simkins, J., Muggia, V. A., Cohen, H. W., & Minamoto, G. Y. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12276 · Cited by 51
Genomic Analysis of a Pan-Resistant Isolate of Klebsiella pneumoniae , United States 2016
de Man, T. J. B., Lutgring, J. D., Lonsway, D. R., Anderson, K. F., Kiehlbauch, J. A., Chen, L., Walters, M. S., Sjölund-Karlsson, M., Rasheed, J. K., Kallen, A. J., et al. (2018) · mBio · doi:10.1128/mbio.00440-18 · Cited by 51
Self-citation
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study
Sotgiu, G., Are, B. M., PESAPANE, L., Palmieri, A., Muresu, N., Cossu, A., Dettori, M., Azara, A., Mura, I., Cocuzza, C. E., et al. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.03.033 · Cited by 51
Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
Jean, S., Lee, N., Tang, H.-J., Lu, M.-C., Ko, W., & Hsueh, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02888 · Cited by 51
Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12
Robert, J., Pantel, A., Mérens, A., Lavigne, J., Nicolas-Chanoine, M.-H., Brieu, N., Vrain, A., Scanvic, A., Porcheret, H., Garnier, P., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku208 · Cited by 50
Modified Hodge Test versus Indirect Carbapenemase Test: Prospective Evaluation of a Phenotypic Assay for Detection of Klebsiella pneumoniae Carbapenemase (KPC) in Enterobacteriaceae
Mathers, A. J., Carroll, J., Sifri, C. D., & Hazen, K. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03240-12 · Cited by 50
Eravacycline for the treatment of intra-abdominal infections
Bassetti, M., & Righi, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.965253 · Cited by 51
Bactericidal Peptidomimetic Polyurethanes with Remarkable Selectivity against Escherichia coli
Mankoci, S., Kaiser, R. L., Sahai, N., Barton, H. A., & Joy, A. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00309 · Cited by 50
Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India
Jaggi, N., Chatterjee, N., Singh, V., Giri, S. K., Dwivedi, P. N., Panwar, R., & Sharma, A. P. (2019) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.66.2019.020 · Cited by 50
Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance
Wachino, J., Jin, W., Kimura, K., Kurosaki, H., Sato, A., & Arakawa, Y. (2020) · mBio · doi:10.1128/mbio.03144-19 · Cited by 50
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis
Bogan, C., Kaye, K. S., Chopra, T., Hayakawa, K., Pogue, J. M., Lephart, P., Bheemreddy, S., Lazarovitch, T., Zaidenstein, R., Pérez, F., et al. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.02.013 · Cited by 49
Complete Nucleotide Sequence of the IncN Plasmid Encoding IMP-6 and CTX-M-2 from Emerging Carbapenem-Resistant Enterobacteriaceae in Japan
Kayama, S., Shigemoto, N., Kuwahara, R., Oshima, K., Hirakawa, H., Hisatsune, J., Jové, T., Nishio, H., Yamasaki, K., Wada, Y., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04759-14 · Cited by 49
Smartphone-based pathogen diagnosis in urinary sepsis patients
Barnes, L., V, Heithoff, D. M., Mahan, S. P., Fox, G. N., Zambrano, A., Choe, J., Fitzgibbons, L. N., Marth, J. D., Fried, J., Soh, H. T., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.001 · Cited by 47
Expanding the Klebsiella pneumoniae volatile metabolome using advanced analytical instrumentation for the detection of novel metabolites
Rees, C. A., Franchina, F. A., Nordick, K. V., Kim, P. J., & Hill, J. E. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13372 · Cited by 47
Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography
Yang, S., Hemarajata, P., Hindler, J. A., Li, F., Adisetiyo, H., Aldrovandi, G. M., Sebra, R., Kasarskis, A., MacCannell, D., Didelot, X., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw876 · Cited by 47
Nosocomial Outbreak of New Delhi Metallo-β-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study
de Jager, P., Chirwa, T. F., Naidoo, S., Perovic, O., & Thomas, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123337 · Cited by 46
Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China
Hu, L., Zhong, Q., Tu, J., Xu, Y., Qin, Z., Parsons, C. H., Zhang, B., Hu, X., Wang, L., Yu, F., et al. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.01.006 · Cited by 46
Epidemiology and economics of adult patients hospitalized with urinary tract infections
Cardwell, S. M., Crandon, J. L., Nicolau, D. P., McClure, M. H., & Nailor, M. D. (2015) · Hospital Practice · doi:10.1080/21548331.2016.1133214 · Cited by 46
Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Ponce‐de‐León, A., Rodríguez-Noriega, E., Morfín‐Otero, R., Cornejo-Juárez, D. P., Tinoco, J. C., Martínez‐Gamboa, A., Gaona-Tapia, C. J., Guerrero-Almeida, M. L., Martin‐Onraët, A., Cervantes, J. L. V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198621 · Cited by 46
Antibacterial effect of copper sulfate against multi-drug resistant nosocomial pathogens isolated from clinical samples
Benhalima, L., Amri, S., Bensouilah, M., & Ouzrout, R. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.5.336 · Cited by 46
The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock
Pop-Vicas, A. E., & Opal, S. M. (2013) · Virulence · doi:10.4161/viru.26210 · Cited by 45
NDM-1-producing Enterobacteriaceae in a teaching hospital in Shanghai, China: IncX3-type plasmids may contribute to the dissemination of blaNDM-1
Qu, H., Wang, X., Ni, Y., Liu, J., Tan, R., Huang, J., Li, L., & Sun, J. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.02.020 · Cited by 45
Epidemiology and Clinical Features of Bloodstream Infections in Hematology Wards: One Year Experience at the Catholic Blood and Marrow Transplantation Center
Kwon, J., Kim, S., Choi, J.-K., Cho, S., Park, Y.-J., Park, S. H., Choi, S., Lee, D., Choi, J., & Yoo, J. (2013) · Infection and Chemotherapy · doi:10.3947/ic.2013.45.1.51 · Cited by 45
Spatial molecular epidemiology of carbapenem-resistant and New Delhi metallo beta-lactamase (blaNDM)-producingEscherichia coliin the piglets of organized farms in India
Pruthvishree, B. S., Kumar, O. R. V., Sinha, D. K., Malik, Y. S., Dubal, Z. B., Desingu, P. A., Shivakumar, M., Krishnaswamy, N., & Singh, B. R. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13455 · Cited by 45
Survey of US wastewater for carbapenem-resistant Enterobacteriaceae
Hoelle, J. M., Johnson, J. R., Johnston, B., Kinkle, B. K., Boczek, L. A., Ryu, H., & Hayes, S. (2019) · Journal of Water and Health · doi:10.2166/wh.2019.165 · Cited by 45
Risk factors and mortality associated with multi-drug-resistant Gram-negative bacterial infection in adult patients following abdominal surgery
Lin, T.-L., Chang, P.-H., Chen, I.-L., Lai, W.-H., Chen, Y., Li, W.-F., Lee, I.-K., & Wang, C.-C. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.09.021 · Cited by 46
The Antimicrobial Resistance Monitoring and Research (ARMoR) Program: The US Department of Defense Response to Escalating Antimicrobial Resistance
Lesho, E. P., Waterman, P. E., Chukwuma, U., McAuliffe, K., Neumann, C. S., Julius, M. D., Crouch, H. K., Chandrasekera, R. M., English, J. F., Clifford, R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu319 · Cited by 44
Klebsiella pneumoniaecarbapenemase (KPC)-producingKlebsiella pneumoniae: a review of epidemiological and clinical aspects
da Silva, R. M., Traebert, J. L., & Galato, D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.681369 · Cited by 44
An Irish outbreak of New Delhi metallo-β-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence
O'Connor, C., Cormican, M., Boo, T. W., McGrath, E., Slevin, B., O'Gorman, A., Commane, M., Mahony, S., O'Donovan, E., Powell, J., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.005 · Cited by 44
Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections
Ng, S. M. S., Sioson, J. S. P., Yap, J. M., Ng, F. M., Ching, H. S. V., Teo, J. W. P., Jureen, R., Hill, J., & Chia, C. S. B. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3114-5 · Cited by 44
Mechanobactericidal, Gold Nanostar Hydrogel-Based Bandage for Bacteria-Infected Skin Wound Healing
Kaul, S., Sagar, P., Gupta, R., Garg, P., Priyadarshi, N., & Singhal, N. K. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c10844 · Cited by 44
Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study
Bart, Y., Paul, M., Eluk, O., Geffen, Y., Rabino, G., & Hussein, K. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.82 · Cited by 44
The risk/benefit of predicting a post‐antibiotic era: Is the alarm working?
Fowler, T., Walker, D., & Davies, S. C. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12399 · Cited by 43
Genomic Epidemiology of Carbapenemase-Producing Klebsiella Pneumoniae in China
Li, C., Jiang, X., Yang, T., Ju, Y., Yin, Z., Yue, L., Ma, G., Wang, X., Jing, Y., Luo, X., et al. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.02.005 · Cited by 42
Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment
Miller, B. M., & Johnson, S. W. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.09.006 · Cited by 43
Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital
Qin, X., Yang, Y., Hu, F., & Zhu, D. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.064865-0 · Cited by 43
Adenosine triphosphate bioluminescence for bacteriologic surveillance and reprocessing strategies for minimizing risk of infection transmission by duodenoscopes
Sethi, S., Huang, R. J., Barakat, M. T., Banaei, N., Friedland, S., & Banerjee, S. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.10.035 · Cited by 43
Assessment of Infection Control Practices for Interventional Techniques: A Best Evidence Synthesis of Safe Injection Practices and Use of Single-Dose Medication Vials
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/e573 · Cited by 40
Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients
Moreno, B. B., Fernández, I., García, V. P., Romero, I. S., Fernández, B. I., Ortega, M. Á. R., Carmona, S. A., Redondo, M. P., & Anuncibay, P. G. (2013) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2013.861608 · Cited by 42
The Role of Antimicrobial Stewardship in Curbing Carbapenem Resistance
Bogan, C., & Marchaim, D. (2013) · Future Microbiology · doi:10.2217/fmb.13.73 · Cited by 42
Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring bla IMP-4 and bla DHA-1 in a neonatal intensive care unit in China
Yu, F., Ying, Q., Chen, C., Li, T., Ding, B., Liu, Y., Lu, Y., Qin, Z., Parsons, C. H., Salgado, C. D., et al. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.043000-0 · Cited by 42
High-throughput and automated diagnosis of antimicrobial resistance using a cost-effective cellphone-based micro-plate reader
Feng, S. W., Tseng, D. K., Carlo, D. D., Garner, O. B., & Özcan, A. (2016) · Scientific Reports · doi:10.1038/srep39203 · Cited by 43
Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem‐resistant Klebsiella pneumoniae isolates
Park, Y., Choi, Q., Kwon, G. C., & Koo, S. H. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23506 · Cited by 42
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022)
Sader, H. S., Mendes, R. E., Duncan, L. R., Kimbrough, J. H., Carvalhaes, C. G., & Castanheira, M. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.115945 · Cited by 41
Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug‐Resistant Enterobacteriaceae
Liu, L., Zha, J., DiGiandomenico, A., McAllister, D. J., Stover, C. K., Wang, Q., & Boons, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505420 · Cited by 41
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea
Kim, S. Y., Shin, J., Shin, S. Y., & Ko, K. S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.04.006 · Cited by 41
In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae
Crandon, J. L., & Nicolau, D. P. (2015) · Pathogens · doi:10.3390/pathogens4030620 · Cited by 41
Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
Lee (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1220w · Cited by 41
A cohort study of bacteremic pneumonia
Guillamet, C. V., Vazquez, R., Noe, J., Micek, S. T., & Kollef, M. H. (2016) · Medicine · doi:10.1097/md.0000000000004708 · Cited by 41
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation
Forcina, A., Baldan, R., Marasco, V., Cichero, P., Bondanza, A., Noviello, M., Piemontese, S., Soliman, C., Greco, R., Lorentino, F., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.234 · Cited by 41
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae
Dean, C. R., Barkan, D. T., Bermingham, A., Blais, J., Casey, F., Casarez, A. D., Colvin, R. A., Fuller, J., Jones, A. K., Li, C., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01200-18 · Cited by 41
Detection of carbapenem-resistant Enterobacteriaceae by chromogenic screening media
Alizadeh, N., Rezaee, M. A., Kafil, H. S., Barhaghi, M. H. S., Memar, M. Y., Milani, M., Hasani, A., & Ghotaslou, R. (2018) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2018.09.001 · Cited by 41
A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections
Xiao, T., Wu, Z., Shi, Q., Zhang, X., Zhou, Y., Xiao, Y., & Xiao, Y. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.12.014 · Cited by 41

Authors: Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J.
Affiliations: Centers for Disease Control and Prevention (US)
ORCID: Gupta, N.
Patel, J. B.
Kallen, A. J.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-06-07
Volume: 53
Issue: 1
Pages: 60-67
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1093/cid/cir202
OpenAlex: W2113898837
Cited by: 1,033
References: 48
Citations by year: 2026: 20 · 2025: 32 · 2024: 36 · 2023: 54 · 2022: 60 · 2021: 68 · 2020: 78 · 2019: 96 · 2018: 80 · 2017: 99 · 2016: 82 · 2015: 92 · 2014: 97 · 2013: 77 · 2012: 54
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Funders: Kimberly-Clark
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Life Sciences › Immunology and Microbiology › Microbiology › Enterobacteriaceae and Cronobacter Research
Keywords: carbapenem-resistant Enterobacteriaceae, KPC, New Delhi metallo-beta-lactamase, mobile genetic elements, infection control, antimicrobial resistance, United States
MeSH terms: Bacterial Proteins, beta-Lactamases, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, Carbapenems, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks